AstraZeneca to buy oncology firm TeneoTwo for up to $1.27 billion

1 min


161
100 shares, 161 points

(Reuters) – AstraZeneca said on Tuesday it will acquire oncology firm TeneoTwo Inc in a deal worth up to $1.27 billion, including the company’s initial stage T-cell engager.

The London-listed drugmaker plans to buy all outstanding equity of TeneoTwo for upfront payment of $100 million on deal close.

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Sherry Jacob-Phillips)

Source: KFGO


Like it? Share with your friends!

161
100 shares, 161 points

What's Your Reaction?

Cute Cute
2
Cute
Fun Fun
21
Fun
Hate Hate
16
Hate
Confused Confused
5
Confused
Fail Fail
24
Fail
Geeky Geeky
18
Geeky
Love Love
10
Love
OMG OMG
5
OMG
Choose A Format
Personality quiz
Series of questions that intends to reveal something about the personality
Trivia quiz
Series of questions with right and wrong answers that intends to check knowledge
Poll
Voting to make decisions or determine opinions
Story
Formatted Text with Embeds and Visuals
List
The Classic Internet Listicles
Countdown
The Classic Internet Countdowns
Open List
Submit your own item and vote up for the best submission
Ranked List
Upvote or downvote to decide the best list item
Meme
Upload your own images to make custom memes
Video
Youtube, Vimeo or Vine Embeds
Audio
Soundcloud or Mixcloud Embeds
Image
Photo or GIF
Gif
GIF format